Fighting Abuse & Counterfeit Drugs: Lessons from the US
- Experts warn of a potential opioid crisis in Europe,drawing lessons from the US experience to prevent a similar catastrophe.
- indicates a decrease in overdose deaths related to fentanyl, a new concern is emerging in Europe.
- The WHO alert also highlights the spread of heroin mixed with nitazene in Scotland.
Europe on Alert: The Looming threat of Fentanyl and Synthetic opioids
Table of Contents
- Europe on Alert: The Looming threat of Fentanyl and Synthetic opioids
- Europe’s Growing Fentanyl Threat: A Q&A Guide
Experts warn of a potential opioid crisis in Europe,drawing lessons from the US experience to prevent a similar catastrophe.
The Rising Concern Over Synthetic Opioids in Europe
While news from the U.S. indicates a decrease in overdose deaths related to fentanyl, a new concern is emerging in Europe. The World Health Institution (WHO) experts have issued an alert regarding the presence of counterfeit oxycodone pills containing nitazene, a potent opioid even stronger than fentanyl.
The WHO alert also highlights the spread of heroin mixed with nitazene in Scotland. This combination significantly elevates the risk of immediate overdose. These developments have captured the attention of Riccardo Gatti, a psychiatrist and psychotherapist specializing in psychoactive substances and addiction.
Learning from the U.S. Opioid Crisis
Gatti emphasizes that “La preoccupazione che il mercato delle droghe e dei farmaci contraffatti in Europa possa diventare ancor più pericoloso e simile a quello Nord Americano rimane realistica” and that “è importante capire cosa ci può insegnare la situazione statunitense.”
He notes that while drug-related deaths are decreasing in 50 U.S. states, the situation remains critical. The current numbers are only returning to pre-COVID-19 pandemic levels, and further decline is uncertain.Gatti stresses that “una volta che si è creata una situazione emergenziale, ritornare indietro richiede anni. Quindi le strategie e le azioni preventive sono fondamentali, assieme ad una capacità ampia di visione su quanto accade nel mondo e potrebbe accadere anche da noi“.
The U.S. Experience: A Cautionary Tale
Gatti recalls that the first wave of opioid overdoses in the U.S. began in the late 1990s, following a severe cocaine and crack epidemic in the 1980s. This initial crisis was attributed to the over-prescription of opioid painkillers.
He points out two critical lessons: first, the current prevalence of cocaine and crack in Italy does not preclude other drug-related crises. Second, increased vigilance is needed regarding potentially addictive medications that are dangerously circulating outside of medical supervision. These substances require strict medical control and appropriate prescriptions.
The Paradox of Increased control
Gatti argues that “un maggior controllo sulle prescrizioni avviato a posteriori negli Usa e non bilanciato da maggior informazione e da una buona accessibilità alla cura delle persone ormai affette da dipendenza da oppioidi ha portato molte di queste a rivolgersi al mercato illecito”. He suggests that “un maggior controllo, in presenza di un’offerta di cura insufficiente e poco accessibile, può avere effetti paradossali pesanti”.
The U.S. response, focused on repressing the illicit market, led to what some call “incarcerazione di massa,” including the imprisonment of drug addicts. Gatti warns that “anche da noi le carceri possono diventare terreno di incubazione e perfezionamento per persone tossicodipendenti”.
The Shift Towards Synthetic Drugs
The U.S.drug market has increasingly shifted towards potent synthetic substances, either mixed with traditional drugs or found in counterfeit medications. Some observers believe that the spread of fentanyl is due to the ease of transporting high-potency synthetics in small quantities, even under strict repressive controls.
While Gatti is not entirely convinced by this theory, he acknowledges the impact of such substances. Regarding Donald Trump’s comparison of fentanyl trafficking to terrorism, Gatti states, “non so se abbia ragione,” but concedes that “in ogni caso tutto ciò ha ulteriormente aumentato il numero di overdose mortali. teniamo presente che anche l’Europa ha molti nemici e i tentativi di destabilizzazione con la diffusione di droghe, nell’ambito di guerre asimmetriche, non sono fantapolitica: fanno parte della storia”.
The Dangers of Drug Cocktails
in the U.S., “i mix di fentanil e xilazina presenti nelle droghe di strada (la xilazina è un tranquillante per animali senza uso approvato dalla Fda nell’uomo) hanno reso i sintomi di astinenza molto più strazianti e più difficili da trattare”. This makes recovery an even greater challenge.
The Future of Drug Markets: A Grim Outlook
gatti warns that “Ciò che possiamo imparare” from the U.S. is that “i mercati delle droghe sono in continua evoluzione, ma il loro futuro sembra già definito: diffusione mix di sostanze attive ad alta potenza, con possibili effetti differenziati, per raggiungere una clientela più ampia, e farmaci contraffatti, in grado di generare rapidamente una forte dipendenza, difficile da trattare. In questo ambito gli oppioidi sintetici ad alta potenza, da soli o in mix con altre droghe classiche o nuove (per esempio fentanyl o nitazeni, più cannabinoidi sintetici), sono una risorsa importante e poco costosa da produrre”.
The Need for Proactive Strategies
Gatti emphasizes that “Poiché i cambiamenti nelle offerte dei mercati clandestini sono relativamente rapidi e le organizzazioni criminali esercitano, ormai, un’azione globalizzata
Europe’s Growing Fentanyl Threat: A Q&A Guide
Understand the rising risks of synthetic opioids and fentanyl in Europe and discover the lessons learned from the US opioid crisis.
Understanding the Fentanyl threat
Fentanyl and other synthetic opioids present a meaningful and evolving threat. This Q&A guide provides insights into the dangers, the lessons from the U.S.,and strategies for prevention.
What is driving the shift towards synthetic drugs in the U.S.?
The U.S. drug market is seeing an increase in potent synthetic substances, often mixed with conventional drugs or found in counterfeit medications. Some beleive that the ease of transporting high-potency synthetics in small quantities, even under strict controls, contributes to fentanyl’s spread.
How does Riccardo Gatti view the comparison of fentanyl trafficking to terrorism?
Riccardo Gatti acknowledges the impact of such substances but is not entirely convinced by the comparison. He states, “non so se abbia ragione,” but concedes that “in ogni caso tutto ciò ha ulteriormente aumentato il numero di overdose mortali.”
What are the concerns about drug cocktails in the U.S.?
In the U.S., fentanyl and xylazine mixtures in street drugs, with xylazine being an animal tranquilizer not approved for human use by the FDA, have made withdrawal symptoms more arduous and painful to treat, increasing recovery challenges.
The Future of Drug Markets and Risk
What is the predicted future of drug markets, according to Gatti?
Gatti warns that the future of drug markets appears set: the spread of high-potency, mixed active substances to reach a wider clientele, and counterfeit drugs that can quickly generate strong addiction, which is difficult to treat.Synthetic opioids like fentanyl or nitazenes, alone or in combination with other classic or new drugs (e.g., synthetic cannabinoids), are key and inexpensive resources to produce.
Strategies and Prevention
Why are proactive strategies essential in addressing this issue?
Gatti emphasizes that changes in the illicit drug market are relatively rapid,and criminal organizations operate globally.This necessitates proactive strategies to keep pace with the evolving nature of the drug trade.
Lessons from the U.S. Opioid Crisis
What lessons can be learned from the US opioid crisis?
Gatti stresses the importance of understanding the U.S. situation as a cautionary tale and emphasizes that once an emergency situation arises, recovery takes years, highlighting the importance of preventive strategies and a broad vision of global events.
What are the key takeaways from the U.S. experience?
Two critical lessons: first,the current prevalence of other drugs like cocaine and crack does not preclude other drug-related crises. Second, increased vigilance is needed for potentially addictive medications circulating outside medical supervision, with stricter medical control and prescription practices.
Key Takeaways: What You Need to Know
Here’s a summary of the most critically important points:
| Concern | Details |
|---|---|
| Synthetic Drugs | Increasing presence of fentanyl and other potent synthetics in the drug market; Ease of transport exacerbates spread. |
| Drug Cocktails | Mixing fentanyl with drugs like xylazine increases risks and makes withdrawal harder. |
| Future Trends | Expansion of potent drug mixtures and counterfeit medications; synthetic opioids as a key component. |
| Need for Action | Proactive strategies are crucial, given the rapid changes and global reach of the drug markets. |